Antivascular cancer treatments: imaging biomarkers in pharmaceutical drug development.
Galbraith
S M
SM
Clinical Discovery, Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, NJ 08453-4000, USA.
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008833:Microcirculation; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy; D009389:Neovascularization, Pathologic / Q000175:diagnosis / Q000188:drug therapy*; D049268:Positron-Emission Tomography / Q000379:methods
D020533:Angiogenesis Inhibitors